Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMMEPKR)

Drug Name

PEG-Interferon lambda (IL-29) Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Virus infection	1A24-1D9Z	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Interleukin-29 (IL29)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Peginterferon lambda-1a	DMK6OFY	Acute myeloid leukaemia	2A60	Phase 3	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT00565539) Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection. U.S. National Institutes of Health.
2	Preclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis C. J Interferon Cytokine Res. 2010 Aug;30(8):591-5.